Status:

COMPLETED

Short Course of Miltefosine and Liposomal Amphotericin B for Kala-azar

Lead Sponsor:

Banaras Hindu University

Collaborating Sponsors:

Rajendra Memorial Research Institute of Medical Sciences

Conditions:

Visceral Leishmaniasis

Eligibility:

All Genders

2-65 years

Phase:

PHASE2

Brief Summary

Miltefosine and liposomal amphotericin B (AmBisome) are approved drugs for visceral leishmaniasis. In this study both drugs will be given in a sequential manner. AmBisome will be given on day 1, follo...

Detailed Description

Methodology Multicenter trial, eligible patients will be treated with Liposomal amphotericin B (5 mg/kg) on day 1 and then with miltefosine capsules for 14 days (days 2-15). At two weeks after the en...

Eligibility Criteria

Inclusion

  • Male and female age between 2 and 65 years (inclusive)
  • Parasites visualized on splenic aspiration
  • Signs and symptoms compatible with visceral leishmaniasis (e.g. fever, splenomegaly, anaemia, weight loss, leucopenia, thrombocytopenia)
  • Confirmed diagnosis of VL by visualization of parasites on splenic/bone marrow aspirate
  • Fever for at least 2 weeks
  • Written informed consent from the patient/or from parent or guardian if under 18 years old

Exclusion

  • Hemoglobin \< 6 g/dl
  • White blood cell count \< 1000/mm3
  • Platelets \<50,000
  • Prothrombin time \> 5 sec above control
  • ASAT \> 3 times the upper limit of normal
  • Serum creatinine or BUN \> 1.5 times the upper limit of normal
  • Malaria
  • Tuberculosis
  • HIV positive serology
  • Lactation, pregnancy
  • Refusing contraception method during treatment period plus 3 months
  • Any medical condition(s) that upon judgment of physician may affect the safety of the patient when treated with study drugs
  • Any concomitant drug that is nephrotoxic

Key Trial Info

Start Date :

October 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 1 2010

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT00371995

Start Date

October 1 2007

End Date

February 1 2010

Last Update

June 22 2011

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Kala-azar Medical Research Center

Muzaffarpur, Bihar, India, 842001

2

Rajendra Memorial Research Institute of Medical Sciences

Patna, Bihar, India

Short Course of Miltefosine and Liposomal Amphotericin B for Kala-azar | DecenTrialz